Sundyota Numandis Pharmaceuticals Private Limited

Pharmaceutical trading company with a wide range of products for various therapeutic segments.

2003 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Sundyota Numandis Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 3.30 Cr
  • Paid Up Capital ₹ 3.30 Cr
  • Company Age 21 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 65.43 Cr
  • Satisfied Charges ₹ 5.39 Cr
  • Revenue Growth 0.81%
  • Profit Growth -24.21%
  • Ebitda -18.25%
  • Net Worth 12.71%
  • Total Assets -2.05%

About Sundyota Numandis Pharmaceuticals

Sundyota Numandis Pharmaceuticals Private Limited (SNPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 May 2003 and has a history of 21 years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Dyota Numandis Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.30 Cr and a paid-up capital of Rs 3.30 Cr.

The company currently has active open charges totaling ₹65.43 Cr. The company has closed loans amounting to ₹5.39 Cr, as per Ministry of Corporate Affairs (MCA) records.

Dinesh Arora and Poonam Arora serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239GJ2003PTC042438

  • Company No.

    042438

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    29 May 2003

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Sundyota Numandis Pharmaceuticals Private Limited offer?

Sundyota Numandis Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Pre & Probiotic Capsule.

Company report

Sundyota Numandis Pharmaceuticals Private Limited

Explore comprehensive data for Sundyota Numandis Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Sundyota Numandis Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Dinesh Arora Country flag representing In Managing Director29-May-2003Current

Board Members (1)

NameDesignationAppointment DateStatus
Poonam Arora Country flag representing In Director 24-Jul-2012Current

Financial Performance of Sundyota Numandis Pharmaceuticals.

Sundyota Numandis Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.81% increase. The company also saw a substantial fall in profitability, with a 24.21% decrease in profit. The company's net worth Soared by an impressive increase of 12.71%.

Sundyota Numandis Pharmaceuticals revenue growth over time
Sundyota Numandis Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
0.81%
Revenue from Operations
2.16%
Total Assets
-2.05%
Profit or Loss
-24.21%
Net Worth
12.71%
EBITDA
-18.25%

What is the Ownership and Shareholding Structure of Sundyota Numandis Pharmaceuticals?

In 2024, Sundyota Numandis Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹65.43 Cr

Satisfied Charges

₹5.39 Cr

Charges Breakdown by Lending Institutions

  • State Bank Of India : 58.78 Cr
  • Others : 6.65 Cr

Latest Charge Details

DateLenderAmountStatus
25 Jan 2019State Bank Of India₹17.28 CrOpen
25 Jan 2019State Bank Of India₹41.50 CrOpen
22 Sep 2009Others₹6.65 CrOpen
07 Apr 20083I Infotech Trusteeship Services Limited₹2.57 CrSatisfied
03 May 2007Icici Bank Limited₹2.07 CrSatisfied

How Many Employees Work at Sundyota Numandis Pharmaceuticals?

Sundyota Numandis Pharmaceuticals has a workforce of 310 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Sundyota Numandis Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sundyota Numandis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundyota Numandis Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sundyota Numandis Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Sundyota Numandis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Others of Rs. 6.65 Cr registered on 22 Sep 2009 with Charge ID 10178662 was modified on 31 May 2024.

  • Balance Sheet

    Sundyota Numandis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Charges

    A charge with State Bank Of India of Rs. 17.28 Cr registered on 25 Jan 2019 with Charge ID 100246560 was modified on 06 Oct 2020.

  • Charges

    A charge with State Bank Of India amounted to Rs. 41.50 Cr with Charge ID 100246563 was registered on 25 Jan 2019.

  • Charges

    A charge with State Bank Of India amounted to Rs. 17.28 Cr with Charge ID 100246560 was registered on 25 Jan 2019.

Frequently asked questions

  • What is the Incorporation or founding date of Sundyota Numandis Pharmaceuticals Private Limited?

    Sundyota Numandis Pharmaceuticals Private Limited was incorporated on 29 May 2003.

  • What is authorized share capital and paid-up capital of Sundyota Numandis Pharmaceuticals Private Limited?

    The authorized share capital of Sundyota Numandis Pharmaceuticals Private Limited is ₹ 3.30 Cr and paid-up capital is ₹ 3.30 Cr.

  • Who are the current board members & directors of Sundyota Numandis Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Sundyota Numandis Pharmaceuticals Private Limited.

    • Dinesh Kumar Arora
    • Poonam Arora
  • What is the registered address of Sundyota Numandis Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sundyota Numandis Pharmaceuticals Private Limited is Dyotanumandishouse 7Thfloor Tower-'A' Safalpegasus 100Ft.Road, Prahladnagar India, Ahmedabad, Gujarat, 380015.

  • What is the corporate identification number (CIN) and company number of Sundyota Numandis Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Sundyota Numandis Pharmaceuticals Private Limited is U24239GJ2003PTC042438 and the company number is 042438 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Sundyota Numandis Pharmaceuticals Private Limited?

    The Official website of Sundyota Numandis Pharmaceuticals Private Limited is https://www.sundyotanumandis.com

  • What has been the recent revenue trend for Sundyota Numandis Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Sundyota Numandis Pharmaceuticals Private Limited has risen by 0.81%.

  • How many employees does Sundyota Numandis Pharmaceuticals Private Limited currently have?

    As Per 2024 financial reports, 310 employees are currently employed by Sundyota Numandis Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Sundyota Numandis Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Sundyota Numandis Pharmaceuticals Private Limited has experienced an upsurge of 12.71%.

  • What are the total open charges for Sundyota Numandis Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Sundyota Numandis Pharmaceuticals Private Limited amount to ₹ 65.43 Cr.

  • When was the last Balance Sheet of Sundyota Numandis Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Sundyota Numandis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors